Second Sight Medical Products, Inc. announced that the Centers for Medicare & Medicaid Services has finalized its Medicare hospital outpatient payment rate of $152,500 for the Argus II Retinal Prosthesis System (Argus II) and the associated surgical implantation procedure for calendar year 2019. Second Sight’s Argus II Retinal Prosthesis System is the only FDA and CE Mark approved device for treating retinitis pigmentosa, with proven implant durability of multiple years.